Frontlight ResearchEarly access
Childhood cancers trials in United States
931 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMolecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- Where
- Houston
- People
- 310
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03039439 - Phase 2Taking peopleNivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- Where
- Bethesda
- Age
- 12 years and over
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03258567 - No phaseTaking peopleClinical and Molecular Characteristics of Primary Aldosteronism in Blacks
- Where
- Bethesda
- Age
- 7 years to 70 years
- People
- 1,150
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT03374215 - Phase 2Taking peopleInnovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Where
- Baltimore, Boston, Indianopolis, Los Angeles, Miami, New York
- Age
- 12 years and over
- People
- 109
- Run by
- Scott R. Plotkin, MD, PhD
See details and how to joinNCT04374305 - No phaseTaking peopleChildhood Cancer Predisposition Study (CCPS)
- Where
- Atlanta, Boston, Houston, Memphis, Philadelphia, Salt Lake City
- People
- 1,050 worldwide
- Run by
- Emory University
See details and how to joinNCT04511806 - Phase 2Taking peopleA Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Akron, Albany, Albuquerque, Allentown, Anaheim, Anchorage, Ann Arbor, Arroyo Grande, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bellevue, Bellflower, Bethesda, Birmingham, Boise, Boston, Bridgeport, Brooklyn, Burlington, Carson City, Chapel Hill, Charleston, Charlotte, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Dearborn, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, El Paso, Falls Church, Fargo, Fontana, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Martinsburg, Maywood, Mesa, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Newark, New Brunswick, New Hyde Park, New Orleans, New York, Niles, Norfolk, Norton Shores, Oakland, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Parkersburg, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reed City, Reno, Renton, Richmond, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, St Louis, Stony Brook, St. Petersburg, Sylvania, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Torrance, Traverse City, Troy, Tucson, Tulsa, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Wyoming, Yakima
- Age
- 1 year to 30 years
- People
- 461 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04546399 - Phase 2Taking peopleTrastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Where
- Ann Arbor, Atlanta, Aurora, Baltimore, Birmingham, Boston, Chicago, Cincinnati, Dallas, Durham, Houston, Indianapolis, Kansas City, Los Angeles, Memphis, Minneapolis, Nashville, New York, Orange, Palo Alto, Philadelphia, Pittsburgh, Portland, Salt Lake City, San Francisco, Seattle, St Louis, St. Petersburg, Valhalla, Washington D.C.
- Age
- 12 years to 39 years
- People
- 55
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04616560 - No phaseTaking peopleTesting Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
- Where
- Ann Arbor, Boston, Charleston, Chicago, Columbia, Columbus, Davis, Fairfax, Hartford, Houston, Lebanon, Los Angeles, New York, Orange, Portland, Seattle, Stanford, St Louis, Tampa
- People
- 1,000
- Run by
- Lung Cancer Mutation Consortium
See details and how to joinNCT04712877 - Phase 1/2Taking peopleCyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
- Where
- Bethesda
- Age
- 12 years and over
- People
- 55
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04750928 - Phase 1/2Taking peopleTesting the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
- Where
- Boston, Houston, Los Angeles, Pittsburgh
- Age
- 12 years and over
- People
- 36
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05019716 - Phase 2Taking peopleTesting Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
- Where
- Bethesda, Columbus, Hartford, Houston, Los Angeles, New Haven, Oklahoma City, Pittsburgh, Trumbull, Washington D.C.
- Age
- 12 years and over
- People
- 27
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05333458 - Phase 1Taking peopleTesting the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
- Where
- Boston, Houston, Los Angeles, Newport Beach, Pittsburgh
- Age
- 12 years and over
- People
- 45
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05372640 - Phase 2Taking peopleTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Where
- Abilene, ‘Aiea, Albuquerque, Allentown, Altoona, Anaconda, Anchorage, Ankeny, Ann Arbor, Appleton, Arroyo Grande, Asheboro, Ashland, Athens, Augusta, Aurora, Aventura, Avon, Baltimore, Barrington, Battle Creek, Beachwood, Bellevue, Belpre, Bemidji, Berlin, Bethesda, Bethlehem, Billings, Birmingham, Bismarck, Bloomington, Boiling Springs, Boise, Boston, Bozeman, Brewer, Brighton, Bristol, Bryn Mawr, Buffalo, Burlington, Caldwell, Canton, Cape Girardeau, Carmichael, Carterville, Carthage, Cedar Rapids, Centerville, Centralia, Charleston, Charlottesville, Chelsea, Chesterfield, Chicago, Chillicothe, Cincinnati, City of Saint Peters, Cleveland, Clinton, Coeur d'Alene, Collierville, Columbia, Columbus, Commack, Coon Rapids, Coral Gables, Creve Coeur, Crown Point, Crystal Lake, Cumberland, Dallas, Danville, Dayton, Dearborn, Decatur, Deerfield Beach, Deer River, DeKalb, Delaware, Des Moines, Dixon, Downers Grove, Dublin, Duluth, Durham, Easley, East Stroudsburg, Eau Claire, Edina, Edmonds, Effingham, Elgin, Elk Grove, Encinitas, Erie, Escanaba, Eureka, Evanston, ‘Ewa Beach, Fairfax, Falls Church, Fargo, Farmington, Farmington Hills, Findlay, Flemington, Flint, Fort Collins, Fort Lauderdale, Franklin, Fruitland, Gainesville, Galesburg, Geneva, Germantown, Glenview, Goldsboro, Goodyear, Grafton, Grand Rapids, Grayslake, Great Falls, Greeley, Green Bay, Greensboro, Greensburg, Greenville, Greer, Grenada, Grove City, Gulfport, Harrison, Harvey, Hazel Crest, Hazleton, Hibbing, Highland Park, High Point, Honolulu, Houston, Huntington, Issaquah, Jacksonville, Janesville, Johnson City, Jonesboro, Kalamazoo, Kalispell, Kenosha, Kettering, Kewanee, Kingman, Kingsport, Lacey, La Crosse, La Jolla, Lake Forest, Lakewood, Lancaster, Lansing, Las Vegas, Lexington, Libertyville, Livingston, Livonia, Long Branch, Los Angeles, Loveland, Lubbock, Macomb, Madison, Manistique, Mansfield, Maple Grove, Maplewood, Marinette, Marion, Marshfield, Martinez, Marysville, Mattoon, Mayfield Heights, Maywood, Mechanicsburg, Media, Memphis, Mentor, Meridian, Metairie, Miami, Michigan City, Middleburg Heights, Middletown, Milwaukee, Mineola, Minneapolis, Minocqua, Missoula, Mobile, Monroeville, Morgantown, Mount Vernon, Mukwonago, Muskegon, Nampa, Nashville, Nassau Bay, Neenah, New Albany, Newark, Newberg, New Brunswick, New Lenox, New London, Newnan, New Orleans, New Richmond, New York, Niles, Normal, North Miami, Norton Shores, Oak Lawn, Oconomowoc, Oconto Falls, O'Fallon, Oklahoma City, Omaha, Ontario, Orange, Oregon City, Orland Park, Oshkosh, Ottawa, Oxford, Paducah, Palo Alto, Paoli, Park Ridge, Pekin, Pennington, Peoria, Perrysburg, Peru, Philadelphia, Phoenix, Pickerington, Pittsburgh, Plantation, Pontiac, Portland, Portsmouth, Post Falls, Princeton, Providence, Racine, Raleigh, Rapid City, Reed City, Reidsville, Reno, Renton, Rice Lake, Richmond, Roanoke, Rochester, Rockford, Rocklin, Rolla, Royal Oak, Sacramento, Saginaw, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, San Diego, Sandpoint, Sandstone, San Francisco, Santa Monica, Sayre, Scarborough, Seattle, Seneca, Sewell, Shawano, Sheboygan, Shiloh, Sioux Falls, Somerville, South Bend, Southhaven, South Hill, South Portland, Springfield, Stevens Point, St Louis, Stoneham, Sturgeon Bay, Sugar Land, Sullivan, Summit, Syracuse, Tawas City, Temple, The Bronx, The Woodlands, Toledo, Toms River, Traverse City, Troy, Twin Falls, Two Rivers, Urbana, Virginia, Walla Walla, Walnut Creek, Warrenville, Washington, Waukee, Waukesha, Waupaca, Wauwatosa, West Allis, West Branch, Westerville, Weston, Whittier, Willow Grove, Winston-Salem, Woodland, Wynnewood, Wyoming, Yakima, Youngstown, Ypsilanti, Zanesville, Zion
- People
- 2,900 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05564377 - Phase 1/2Taking people000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- Where
- Bethesda, Jacksonville
- Age
- 15 years to 99 years
- People
- 96
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05588141 - Phase 3Taking peopleA Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Where
- Akron, Albany, Albuquerque, Allentown, Anchorage, Ankeny, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baker City, Baltimore, Bangor, Barrington, Bath, Battle Creek, Bellevue, Bethesda, Birmingham, Boiling Springs, Boise, Boston, Brighton, Brownstown, Buffalo, Burlington, Caldwell, Camden, Camillus, Canton, Cape Girardeau, Carmichael, Carroll, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chelsea, Chesterfield, Chicago, Cincinnati, City of Saint Peters, Cleveland, Clinton Township, Clive, Colorado Springs, Columbia, Columbus, Coon Rapids, Corona, Corpus Christi, Costa Mesa, Creve Coeur, Crystal Lake, Cudahy, Dallas, Danville, Dayton, Dearborn, Decatur, DeKalb, Denver, Derby, Des Moines, Detroit, Downers Grove, Downey, Duarte, Dublin, Durham, East Lansing, East Syracuse, Edina, Effingham, Elgin, Elizabeth, Elk Grove, Elmhurst, El Paso, Evanston, Fairfield, Falls Church, Fargo, Farmington Hills, Flemington, Fort Collins, Fort Lauderdale, Fort Myers, Fort Worth, Fremont, Fresno, Fruitland, Gainesville, Geneva, Germantown, Glastonbury, Glens Falls, Glenview, Goodyear, Grafton, Grand Rapids, Grayslake, Greeley, Green Bay, Greenville, Greenwich, Guilford, Hackensack, Hartford, Hazel Crest, Hershey, Highland Park, Hollywood, Honolulu, Houston, Huntington, Huntington Beach, Indianapolis, Iowa City, Irvine, Jackson, Jacksonville, Jersey City, Kalamazoo, Kansas City, Kenosha, Knoxville, La Crosse, Lake Forest, Lancaster, Las Vegas, Lebanon, Lexington, Libertyville, Little Rock, Livingston, Livonia, Loma Linda, Long Beach, Long Branch, Los Angeles, Louisville, Loveland, Lubbock, Macomb, Macon, Madera, Madison, Marinette, Marshfield, Mattoon, Maywood, Meridian, Mesa, Miami, Miami Beach, Milwaukee, Mineola, Minneapolis, Mobile, Modesto, Morristown, Mukwonago, Muskegon, Nampa, Naperville, Nashville, Neptune City, Newark, Newberg, New Brunswick, New Haven, New Hyde Park, New Orleans, Newport Beach, New York, Norfolk, North Haven, Norton Shores, Novi, Oakland, Oak Lawn, Oconomowoc, O'Fallon, Oklahoma City, Omaha, Ontario, Orange, Oregon City, Orlando, Orland Park, Oshkosh, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Plainfield, Pontiac, Portland, Portsmouth, Providence, Racine, Reed City, Reno, Renton, Richmond, Roanoke, Rochester, Rockford, Rocklin, Royal Oak, Sacramento, Saint Joseph, Saint Louis Park, Saint Paul, Salt Lake City, San Antonio, San Diego, Sanford, San Francisco, San Jose, San Leandro, San Rafael, Santa Barbara, Santa Rosa, Savannah, Scarborough, Seattle, Seneca, Sheboygan, Shiloh, Sioux Falls, Southfield, South Pasadena, South Portland, South San Francisco, Spokane, Springfield, Stamford, St Louis, Stony Brook, St. Petersburg, Sturgeon Bay, Summit, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Toms River, Torrance, Torrington, Traverse City, Troy, Trumbull, Tulsa, Twin Falls, Two Rivers, Upland, Urbana, Vallejo, Walnut Creek, Warrenville, Washington D.C., Waterbury, Waterford, Waukee, Waukesha, Wauwatosa, Webster, West Allis, West Bloomfield, Westerly, West Palm Beach, Wichita, Williamsville, Wilmington, Winston-Salem, Woodbury, Woodland, Worcester, Wyandotte, Wyoming, Yorkville, Ypsilanti
- Age
- 5 years to 60 years
- People
- 1,875 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05675410 - Phase 1/2Taking peopleTINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Where
- Charlotte, Hershey, Houston, Little Rock, Los Angeles, Madera, Minneapolis, New York, Norfolk, Orange, Orlando, Palo Alto, Phoenix, Portland, Salt Lake City, San Antonio, San Diego
- Age
- Up to 1 year
- People
- 90 worldwide
- Run by
- Tanja Andrea Gruber
See details and how to joinNCT05848687 - Phase 1Taking peopleSafety and Feasibility of Intraoperative Visualization With Cytalux in Children
- Where
- Chicago
- Age
- 6 years to 17 years
- People
- 10
- Run by
- Ann & Robert H Lurie Children's Hospital of Chicago
See details and how to joinNCT06235125 - No phaseTaking peopleGenerating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- Where
- Buffalo, Columbus, Hartford, Lexington, Miami, Tampa
- People
- 35
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06423950 - Phase 2Taking peoplePhase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
- Where
- Houston
- Age
- 12 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06444880 - Phase 1/2Taking peopleSilmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Where
- Birmingham, Charleston, Dallas, Detroit, Gainesville, Hackensack, Hartford, Hershey, Honolulu, Kansas City, Louisville, Miami, Milwaukee, Nashville, Oakland, Orlando, Phoenix, Providence, Richmond, Sacramento, Salt Lake City, San Diego, St Louis, St. Petersburg, Tampa
- Age
- Up to 30 years
- People
- 104 worldwide
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT06541262 - Phase 1/2Taking peopleTrial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Where
- Albuquerque, Atlanta, Boston, Buffalo, Cleveland, Dallas, Detroit, Houston, Indianapolis, Irvine, Jacksonville, Longmont, New York, Norfolk, Omaha, Philadelphia, Phoenix, Pittsburgh, Rochester, Salt Lake City, San Diego, Santa Monica, Seattle, St Louis
- People
- 64 worldwide
- Run by
- RayzeBio, Inc.
See details and how to joinNCT06590857 - Phase 1Taking peopleA Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- Where
- Boston, Duarte, Houston, Newport Beach, New York
- Age
- 16 years and over
- People
- 171
- Run by
- SEED Therapeutics, Inc.
See details and how to joinNCT07197554 - Phase 3Taking peopleA Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
- Where
- Cincinnati, Houston, Memphis, New York, Philadelphia
- Age
- 1 year to 64 years
- People
- 130 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07223021 · EU 2025-523096-34-00 - No phaseTaking peopleA Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
- Where
- Detroit
- People
- 160
- Run by
- Henry Ford Health System
See details and how to joinNCT07348367 - Phase 1Not yet taking people in United StatesAutologous iC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma
- Where
- Houston
- Age
- 16 years to 75 years
- People
- 21
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT07729397